Back
BeiGene Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
43
BGNE
BeiGene
Last Price:
206.47
Seasonality Move:
15.02%
Sell
46
RARE
Ultragenyx Pharmaceutical
Last Price:
52.02
Seasonality Move:
11.62%
Sell
43
BeiGene (BGNE)
is a Sell
Is BeiGene a Buy, Sell or Hold?
- The current BeiGene [BGNE] share price is $216.53. The Score for BGNE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- BGNE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $52.80. The Score for RARE is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BGNE Stock Price Chart
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $52.80
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight selling pressure.
BGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.16 | Buy |
| Relative Strength Index (14 RSI): | 48.21 | Sell |
| Chaikin Money Flow: | -60094 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (214.13 - 235.75) | Sell |
| Bollinger Bands (100): | (156.36 - 214.9) | Buy |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.44 | Sell |
| Relative Strength Index (14 RSI): | 38.95 | Sell |
| Chaikin Money Flow: | -138218 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.44 - 56.38) | Sell |
| Bollinger Bands (100): | (43.42 - 56.66) | Buy |
BGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 217.66 | Sell |
| 20-day SMA: | 227.58 | Sell |
| 50-day SMA: | 210.74 | Buy |
| 200-day SMA: | 170.97 | Buy |
| 8-day EMA: | 218.47 | Sell |
| 20-day EMA: | 220.26 | Sell |
| 50-day EMA: | 209.9 | Buy |
| 200-day EMA: | 184.87 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.34 | Sell |
| 20-day SMA: | 54.67 | Sell |
| 50-day SMA: | 55.89 | Sell |
| 200-day SMA: | 47.69 | Buy |
| 8-day EMA: | 54.09 | Sell |
| 20-day EMA: | 54.76 | Sell |
| 50-day EMA: | 54.11 | Sell |
| 200-day EMA: | 48.72 | Buy |
BeiGene Earnings Growth & BGNE Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.08 per share, and an increase next year of $4.67 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.05 per share, and an increase next year of $1.10 per share.
BeiGene Technical Analysis
| Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||